Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification.

Riaz IB; Cheng L; Montironi R

doi:10.1016/j.eururo.2025.09.4164

← 뒤로

Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification.

0/5 보강

European urology 2026 Vol.89(2) p. 149-150

Riaz IB, Cheng L, Montironi R

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Riaz IB, Cheng L, Montironi R (2026). Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification.. European urology, 89(2), 149-150. https://doi.org/10.1016/j.eururo.2025.09.4164

MLA Riaz IB, et al.. "Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification.." European urology, vol. 89, no. 2, 2026, pp. 149-150.

PMID 41076404

DOI 10.1016/j.eururo.2025.09.4164

같은 제1저자의 인용 많은 논문 (2)

Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
European urology 2026
Treatment Sequencing in Advanced Urothelial Cancer.
Drugs 2026